Leaders in Global Health Honored at 9th Annual Project HOPE Gala
June 14, 2016 09:14 ET
|
Project HOPE
MILLWOOD, VA., June 14, 2016 (GLOBE NEWSWIRE) -- Project HOPE, the global health education and humanitarian assistance organization, today announced the recipients of the Project HOPE Global Health...
![Taxonomer](http://www.globenewswire.com/en/Attachment/LogoDisplay/394729?filename=394729.jpg&size=2)
Ultra-fast, Meta-genomics Pathogen Detection Software for Diagnosing Infectious Diseases
May 26, 2016 14:22 ET
|
ARUP Laboratories
SALT LAKE CITY, May 26, 2016 (GLOBE NEWSWIRE) -- Scientists at the University of Utah, ARUP Laboratories, and IDbyDNA, Inc., have developed ultra-fast, meta-genomics analysis software called Taxonomer...
Battelle Infectious Diseases and Medical Countermeasure Work Awarded With New $59 Million Contract
May 23, 2016 14:25 ET
|
Battelle
COLUMBUS, OH--(Marketwired - May 23, 2016) - Battelle has again been chosen to protect our warfighters and the general public against dangerous infectious disease and chemical threats under a...
![EbolaSuit_NewHood20141211_135159](http://www.globenewswire.com/en/Attachment/LogoDisplay/357403?filename=357403.jpg&size=2)
Johns Hopkins' Ebola Protective Suit Honored in Fast Company 'Innovation by Design Awards'
September 15, 2015 13:30 ET
|
Jhpiego
BALTIMORE, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Related video: https://youtu.be/kRab2bGahCE
The Johns Hopkins University's new personal protective suit for frontline health care workers in Ebola...
Hemispherx Biopharma Europe N.V./S.A.: Orphan Medicine Designation and European Medicines Agency Public Opinion Summary Published by EMA Regarding Ampligen/Rintatolimod for Ebola Virus Disease (EVD)
May 26, 2015 12:46 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that the European Medicines Agency (EMA) has published on May 22,...
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation by the European Medicines Agency for Ampligen to Treat Patients With Ebola Virus Disease (EVD)
May 11, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 11, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that its European subsidiary, Hemispherx Biopharma Europe N.V./S.A.,...
![The National Patient Safety Foundation Logo](/news-release/logo/331969/0/331969.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A21&size=2)
National Patient Safety Foundation DAISY Award Honorees Announced
April 21, 2015 09:37 ET
|
The National Patient Safety Foundation
BOSTON, April 21, 2015 (GLOBE NEWSWIRE) -- The National Patient Safety Foundation (NPSF) and the DAISY Foundation have announced the recipients of the National Patient Safety Foundation's DAISY Award...
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion on Application for Orphan Designation by the European Medicines Agency for Ampligen to Treat Patients With Ebola Virus Disease (EVD)
March 24, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, March 24, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that the European subsidiary, "Hemispherx Biopharma Europe...
Hemispherx Biopharma to Present Data on the Activity of Ampligen(R) Against the Ebola Virus
March 23, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, March 23, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") will present integrated findings of new studies of Ampligen®...
Hemispherx Biopharma and USAMRIID to Present New Discoveries Concerning the Efficacy of Ampligen(R) Against the Ebola Virus at Upcoming International Symposium on Filoviruses
February 12, 2015 08:30 ET
|
AIM ImmunoTech Inc.
Ampligen® May Be an Important Candidate for EBOV Testing in West Africa
PHILADELPHIA, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or...